Skip to product information
1 of 1

Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived

Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived

Regular price $1,049.14
Regular price Sale price $1,049.14
Sold out
Shipping calculated at checkout.
Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived

LumiraDx™ SARS-CoV-2 Ag Antigen Detection Respiratory Test Kit

  • Results in 12 minutes
  • Results are for the identification of SARS-CoV-2 nucleocapsid protein...
29 people are viewing this right now

AvailabilityLow stock: 50 left

ITEM UOM
SKU: 1197690_EA
Vendor: LumiraDx Inc
Category: Unknown Type
Tags:

Shipping & Returns

Free shipping and returns available on all orders!

We ship all US domestic orders within 5-10 business days

Materials

The item with the Committed label has a lower environmental impact because it was made with sustainable materials or methods. We are committed to creating items that combine sustainability with style. Made with recycled cashmere and industril by products.

Size Chart

Care Instructions

We advise routinely dusting your items with a gentle cleanser to preserve its look. Periodically, it may need to be softly wet with a mild detergent solution.

View full product details
Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived

LumiraDx™ SARS-CoV-2 Ag Antigen Detection Respiratory Test Kit

  • Results in 12 minutes
  • Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen; antigen is generally detectable in nasal swab specimens during the acute phase of infection.
  • The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2.
  • Rapid microfluidic immunofluorescence assay test method
  • LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization only.
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests.
  • Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
  • LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument.
  • 48 tests

REAGENT, SARS-COV-2 ANTIGEN TEST STRIP KIT (48TEST/EA)

Application: Respiratory Test Kit